1. Home
  2. BLTE vs RYN Comparison

BLTE vs RYN Comparison

Compare BLTE & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$161.06

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Logo Rayonier Inc. REIT

RYN

Rayonier Inc. REIT

N/A

Current Price

$21.20

Market Cap

6.4B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
BLTE
RYN
Founded
2018
1926
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.4B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
BLTE
RYN
Price
$161.06
$21.20
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$198.00
$26.00
AVG Volume (30 Days)
153.2K
2.8M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
11.73%
EPS Growth
N/A
26.78
EPS
N/A
N/A
Revenue
N/A
$484,485,000.00
Revenue This Year
N/A
$214.97
Revenue Next Year
$492.11
$10.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$62.18
$19.49
52 Week High
$200.00
$27.10

Technical Indicators

Market Signals
Indicator
BLTE
RYN
Relative Strength Index (RSI) 51.24 45.05
Support Level $158.32 $20.97
Resistance Level $172.02 $21.90
Average True Range (ATR) 6.82 0.51
MACD -0.74 -0.07
Stochastic Oscillator 27.85 20.80

Price Performance

Historical Comparison
BLTE
RYN

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About RYN Rayonier Inc. REIT

Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.

Share on Social Networks: